TLRY vs TNXP · rev $915.5M vs rev $20.4M
Tilray Inc (TLRY) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.
TLRY currently screens at market cap $573.9M. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the TLRY and TNXP stock pages for the full models.
Not investment advice.